Skip to main content

Rigging of the first Cyclone® KIUBE in Irak!

-

Monday, February 15, 2021 - 7:53

<p><span><span>The Cyclone® KIUBE was placed into its final position at Karabala Al Muqadasa site in Irak. This IntegraLab® project includes a Cyclone® KIUBE, Synthera®+ multi-tracer radiochemistry platform as well as hot cells and QC equipment. The new radiopharmacy will be dedicated to the production of FDG.</span></span></p> <p><span><span>Congratulations to Nazar Shaaban, <span>Mustafa </span><span>Qussay,&nbsp;</span>Hubert Oldenhove, Maria Simo Falgas&nbsp;and all the people involved! </span></span></p>
Share

More news

webinar psma2021

Webinar - 68Ga-PSMA : from production to clinical applications

Numerous clinical trials with Ga-PSMA PET/CT have demonstrated that this procedure outperforms current standard imaging for both specificity and sensitivity. It is used to detect sites of prostate cancer allowing complete evaluation of the local tumor and lymph nodes, visceral and bone metastases with high accuracy in only one examination.&nbsp; IBA invites you to attend a free webinar presented by 2 leading figures of Nuclear Medicine: Prof Francisco Alves and Dr Jeremie Calais.&nbsp; When? February 23rd, 5-6 pm CET (11-12 am EST) &nbsp;&nbsp; What will you learn from the webinar ?&nbsp; •&nbsp;&nbsp; &nbsp; &nbsp;68Ga Production process from a cyclotron: why &amp; how? &nbsp; By Francisco Alves, Chief physicist &amp; head of Cyclotron at ICNAS-University of Coimbra in Portugal.&nbsp; Prof Alves will share his expertise on the production process of &nbsp;68Ga from cyclotron using a liquid target to labelling. He will give a financial insight on the cyclotron versus generator production based on his site experience and context. &nbsp;&nbsp; •&nbsp;&nbsp; &nbsp;Diagnostic efficacy of &nbsp;68Ga-PSMA versus conventional imaging in prostate cancer patients By Jeremie Calais, Director of the Clinical Research Program of the Nuclear Medicine and Theranostics Division at UCLA. Dr. Calais will compare &nbsp;68Ga-PSMA PET-CT Imaging with conventional modalities and its impact in the management of patient with prostate cancer.&nbsp; &nbsp;&nbsp; Register
See more